To stir up support for the fight against cancer, Pfizer has turned to one of the most iconic pep talks of all time. | To stir ...

Pfizer Inc. (NYSE:PFE) is one of the best medical research stocks to buy according to hedge funds. Pfizer Inc. (NYSE:PFE) ...

It's worth taking a second look at the healthcare giant.

Historical patterns indicate that abrupt fluctuations in the market can impact any firm, regardless of its seeming dominance.

The stock has been fairly stable over the past year.

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Pfizer Inc. (NYSE:PFE) is included among the Dividend Champions, Contenders, and Challengers List: 15 Highest Yielding Stocks ...

In lieu of a Super Bowl ad this year, Pfizer has unveiled a year-long cancer campaign that aims to encourage screening.

Pfizer made one thing clear this week: It's officially back in the obesity race.

A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in ...

Pfizer Inc. (PFE) shares are trading higher on Tuesday, as the stock benefits from a price target increase at Cantor ...

Is Pfizer stock a buy at under 9x earnings? Yes. It is.